Clinical Trial

Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this study is to assess the prevalence of nonalcoholic fatty liver disease (NAFLD) in patients with type 1 diabetes receiving care at Joslin clinic using noninvasive imaging and serum-based methods with the goal of identifying high-risk patients with advanced fibrosis who should be prioritized for specialty referral
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2020-10-19; most recent amendment 2026-05-27.
Status change: Recruiting → Active, Not Recruiting 2022-09-16
Status change: Not Yet Recruiting → Recruiting 2021-01-21
Trial Details
NCT Number NCT04595474
Lead Sponsor Joslin Diabetes Center
Conditions Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis, Fibrosis, Liver, Type 1 Diabetes, Cirrhosis, Liver
Enrollment 533 participants
Start Date 2021-01-14
Primary Completion 2022-08-19 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-29